{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T04:00:08Z","timestamp":1793505608388,"version":"4.5.0"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["atherosclerosis-journal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.atherosclerosis.2025.119138","type":"journal-article","created":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T19:01:36Z","timestamp":1739905296000},"page":"119138","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Statin adherence in coronary outpatients: The relationship between a novel blood test and pharmacy registry data"],"prefix":"10.1016","volume":"403","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3474-3198","authenticated-orcid":false,"given":"Jonas","family":"Pivoriunas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid","family":"Engebretsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nils Tore","family":"Vethe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oscar","family":"Kristiansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toril","family":"Dammen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Einar","family":"Husebye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morten W.","family":"Fagerland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Munkhaugen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elise","family":"Sverre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2025.119138_bib1","series-title":"Adherence to Long-Term Therapies: Evidence for Action","author":"Sabat\u00e9","year":"2003"},{"key":"10.1016\/j.atherosclerosis.2025.119138_bib2","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1093\/ehjcvp\/pvz079","article-title":"An expert opinion paper on statin adherence and implementation of new lipid-lowering medications by the ESC Working Group on Cardiovascular Pharmacotherapy: barriers to be overcome","volume":"6","author":"Drexel","year":"2020","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"10.1016\/j.atherosclerosis.2025.119138_bib3","doi-asserted-by":"crossref","first-page":"3720","DOI":"10.1093\/eurheartj\/ehad191","article-title":"2023 ESC Guidelines for the management of acute coronary syndromes","volume":"44","author":"Byrne","year":"2023","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.atherosclerosis.2025.119138_bib4","first-page":"1","article-title":"2019 ESC\/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk","author":"Mach","year":"2019","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.atherosclerosis.2025.119138_bib5","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1056\/NEJMra050100","article-title":"Adherence to medication","volume":"353","author":"Osterberg","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2025.119138_bib6","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0201196","article-title":"Systematic review of the predictors of statin adherence for the primary prevention of cardiovascular disease","volume":"14","author":"Hope","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.atherosclerosis.2025.119138_bib7","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/j.1742-7843.2009.00494.x","article-title":"The nordic countries as a cohort for pharmacoepidemiological research","volume":"106","author":"Furu","year":"2010","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.atherosclerosis.2025.119138_bib8","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/FTD.0000000000000578","article-title":"A method for direct monitoring of atorvastatin adherence in cardiovascular disease prevention: quantification of the total exposure to parent drug and major metabolites using 2-channel chromatography and tandem mass spectrometry","volume":"41","author":"Vethe","year":"2019","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.atherosclerosis.2025.119138_bib9","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1097\/FTD.0000000000000992","article-title":"Monitoring simvastatin adherence in patients with coronary heart disease: a proof-of-concept study based on pharmacokinetic measurements in blood plasma","volume":"44","author":"Vethe","year":"2022","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.atherosclerosis.2025.119138_bib10","doi-asserted-by":"crossref","first-page":"2878","DOI":"10.1111\/bcp.14122","article-title":"A novel direct method to determine adherence to atorvastatin therapy in patients with coronary heart disease","volume":"85","author":"Kristiansen","year":"2019","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.atherosclerosis.2025.119138_bib11","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1093\/ehjcvp\/pvae001","article-title":"Validation of a novel direct method to determine reduced adherence to atorvastatin therapy","volume":"10","author":"Pivoriunas","year":"2024","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"10.1016\/j.atherosclerosis.2025.119138_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/14017431.2015.1111408","article-title":"The role of medical and psychosocial factors for unfavourable coronary risk factor control","volume":"50","author":"Munkhaugen","year":"2016","journal-title":"Scand. Cardiovasc. J."},{"key":"10.1016\/j.atherosclerosis.2025.119138_bib13","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1185\/03007990903126833","article-title":"Good and poor adherence: optimal cut-point for adherence measures using administrative claims data","volume":"25","author":"Karve","year":"2009","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.atherosclerosis.2025.119138_bib14","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.f2125","article-title":"Clinicians are right not to like Cohen's \u03ba","volume":"346","author":"de Vet","year":"2013","journal-title":"Bmj"},{"key":"10.1016\/j.atherosclerosis.2025.119138_bib15","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/S0895-4356(98)00048-1","article-title":"Approximate standard errors and confidence intervals for indices of positive and negative agreement","volume":"51","author":"Graham","year":"1998","journal-title":"J. Clin. Epidemiol."},{"key":"10.1016\/j.atherosclerosis.2025.119138_bib16","article-title":"Longitudinal control of lipid levels in patients with premature coronary artery disease","volume":"2","author":"Vikulova","year":"2023","journal-title":"JACC (J. Am. Coll. Cardiol.): Advances"},{"key":"10.1016\/j.atherosclerosis.2025.119138_bib17","article-title":"Statin adherence and effects on outcome in premature coronary artery disease","volume":"2","author":"Naqvi","year":"2023","journal-title":"JACC (J. Am. Coll. Cardiol.): Advances"},{"key":"10.1016\/j.atherosclerosis.2025.119138_bib18","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.amjmed.2011.12.013","article-title":"Adherence to drugs that prevent cardiovascular disease: meta-analysis on 376,162 patients","volume":"125","author":"Naderi","year":"2012","journal-title":"Am. J. Med."},{"key":"10.1016\/j.atherosclerosis.2025.119138_bib19","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.ahj.2007.12.011","article-title":"Medication nonadherence is associated with a broad range of adverse outcomes in patients with coronary artery disease","volume":"155","author":"Ho","year":"2008","journal-title":"Am. Heart J."},{"key":"10.1016\/j.atherosclerosis.2025.119138_bib20","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1002\/pds.1230","article-title":"Methods for evaluation of medication adherence and persistence using automated databases","volume":"15","author":"Andrade","year":"2006","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"10.1016\/j.atherosclerosis.2025.119138_bib21","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/pds.4706","article-title":"A systematic review of methods for determining cross-sectional active medications using pharmacy databases","volume":"28","author":"Anderson","year":"2019","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"10.1016\/j.atherosclerosis.2025.119138_bib22","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/217047","article-title":"Medication adherence measures: an overview","volume":"2015","author":"Lam","year":"2015","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.atherosclerosis.2025.119138_bib23","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.atherosclerosis.2021.09.020","article-title":"The relationship between directly measured statin adherence, self-reported adherence measures and cholesterol levels in patients with coronary heart disease","volume":"336","author":"Kristiansen","year":"2021","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2025.119138_bib24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0185471","article-title":"Medication adherence, medical record accuracy, and medication exposure in real-world patients using comprehensive medication monitoring","volume":"12","author":"Ryan","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.atherosclerosis.2025.119138_bib25","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2018.4196","article-title":"Assessment of patient medication adherence, medical record accuracy, and medication blood concentrations for prescription and over-the-counter medications","volume":"1","author":"Sutherland","year":"2018","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.atherosclerosis.2025.119138_bib26","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jclinepi.2021.02.015","article-title":"Self-reported medication use among coronary heart disease patients showed high validity compared with dispensing data","volume":"135","author":"Pedersen","year":"2021","journal-title":"J. Clin. Epidemiol."},{"key":"10.1016\/j.atherosclerosis.2025.119138_bib27","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1177\/2047487317693134","article-title":"Medical and psychosocial factors and unfavourable low-density lipoprotein cholesterol control in coronary patients","volume":"24","author":"Munkhaugen","year":"2017","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.atherosclerosis.2025.119138_bib28","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.d12","article-title":"Monitoring adherence to drug treatment by using change in cholesterol concentration: secondary analysis of trial data","volume":"342","author":"Bell","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.atherosclerosis.2025.119138_bib29","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1136\/bmj.38875.675486.55","article-title":"A meta-analysis of the association between adherence to drug therapy and mortality","volume":"333","author":"Simpson","year":"2006","journal-title":"BMJ"},{"key":"10.1016\/j.atherosclerosis.2025.119138_bib30","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-48540-3","article-title":"Statin treatment after acute coronary syndrome: adherence and reasons for non-adherence in a randomized controlled intervention trial","volume":"9","author":"Huber","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.atherosclerosis.2025.119138_bib31","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s40292-016-0158-z","article-title":"Adherence to antihypertensive therapy and therapeutic dosage of antihypertensive drugs","volume":"23","author":"Rabbia","year":"2016","journal-title":"High Blood Pres. Cardiovasc. Prev."}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915025000358?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915025000358?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T16:28:16Z","timestamp":1762187296000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915025000358"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":31,"alternative-id":["S0021915025000358"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2025.119138","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Statin adherence in coronary outpatients: The relationship between a novel blood test and pharmacy registry data","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2025.119138","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"119138"}}